"My lab program has really taken off and I have been lucky to join researchers at the forefront of brain tumour research, as we continue to find clues to what drives medulloblastoma, glioblastoma and brain metastases. We have won many national grants, we have published well and extensively and I am participating in many national and international research activities from speaking at conferences to chairing grant reviews for CIHR and NIH. I have trained many successful graduates now in the past 5 years, many of whom have joined MD PhD programs to become future clinician scientists. I just came back from the International Society for Neuro-oncology Pediatric Transitional Brain Tumour Research meeting and there are many new and exciting developments and collaborations."
Dr. Sheila Singh joined the McMaster Stem Cell and Cancer Research Institute in July 2007. Prior to her arrival at McMaster University, Sheila completed a PhD at the Hospital for Sick Children. She obtained her degree within the Surgeon Scientist Training Program at the University of Toronto, where she completed her residency and fellowship training specializing in pediatric neurosurgery. She holds a Tier 2 Canada Research Chair in Human Cancer Stem Cell Biology.
Personal words from Dr. Sheila Singh:
"Kelsey was an exceptional child and I felt grateful just to meet her and know her. I will never forget her and the work we do in my lab everyday is a tribute to Kelsey and all of the patients I have lost to cancer. Kelsey and those other patients are my inspiration and the inspiration of my whole lab team. We would be beyond honoured to have your support!"
Kelsey was first diagnosed at McMaster Children's Hospital located in Hamilton, Ontario, on September 16, 2010. Kelsey's protocol and treatment plan was lead by Dr. Sheila Singh and her team. Kelsey received the best possible treatment available and spending so much time at the hospital, the Doctors, nurses and staff begin to feel like family. Team Kelsey will continue to support McMaster Children's Hospital and more specifically to Dr. Sheila Singh's Stem Cell & Cancer Research Institute.